Paper35106955
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.
Head RJ and 7 others. Pharmacol Res Perspect, 2022. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. Papers, record 35106955. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106955
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| SARS-CoV-2 | Major topic |
| Systems Analysis | Major topic |
| Thermodynamics | Major topic |
| Animals | |
| Chiroptera | |
| Humans | |
| Inflammasomes | |
| Nasopharynx | |
| Viral Tropism | |
| Virus Internalization | |
| COVID-19 Drug Treatment |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35106934 | Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology. | https://conductscience.org/library/papers/35106934 |
Source PubMed
References108
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32737833 | Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. | Infection | 2020 | https://conductscience.org/library/papers/32737833 | PubMed |
| 2 | 34022142 | SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. | Lancet Infect Dis | 2021 | https://conductscience.org/library/papers/34022142 | PubMed |
| 3 | 26821017 | Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26821017 | PubMed |
| 4 | 32765942 | Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients. | Aging Dis | 2020 | https://conductscience.org/library/papers/32765942 | PubMed |
| 5 | 32755673 | SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. | Travel Med Infect Dis | 2020 | https://conductscience.org/library/papers/32755673 | PubMed |
| 6 | 20335495 | Identification of key amino acid residues required for horseshoe bat angiotensin-I converting enzyme 2 to function as a receptor for severe acute respiratory syndrome coronavirus. | J Gen Virol | 2010 | https://conductscience.org/library/papers/20335495 | PubMed |
| 7 | 35106955 | Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106955 | PubMed |
| 8 | 15344878 | Thermodynamics of protein-ligand interactions: history, presence, and future aspects. | J Recept Signal Transduct Res | 2004 | https://conductscience.org/library/papers/15344878 | PubMed |
| 9 | 32380510 | Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. | Nature | 2020 | https://conductscience.org/library/papers/32380510 | PubMed |
| 10 | 33106671 | Spike mutation D614G alters SARS-CoV-2 fitness. | Nature | 2021 | https://conductscience.org/library/papers/33106671 | PubMed |
| 11 | 33889552 | IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33889552 | PubMed |
| 12 | 33928117 | Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33928117 | PubMed |
| 13 | 33836016 | Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33836016 | PubMed |
| 14 | 33424191 | Mathematical prediction of the spreading rate of COVID-19 using entropy-based thermodynamic model. | Indian J Phys Proc Indian Assoc Cultiv Sci (2004) | 2021 | https://conductscience.org/library/papers/33424191 | PubMed |
| 15 | 20567988 | Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. | Arch Virol | 2010 | https://conductscience.org/library/papers/20567988 | PubMed |
| 16 | 32954038 | Thermodynamic insight into viral infections 2: empirical formulas, molecular compositions and thermodynamic properties of SARS, MERS and SARS-CoV-2 (COVID-19) viruses. | Heliyon | 2020 | https://conductscience.org/library/papers/32954038 | PubMed |
| 17 | 22966141 | Human viruses: discovery and emergence. | Philos Trans R Soc Lond B Biol Sci | 2012 | https://conductscience.org/library/papers/22966141 | PubMed |
| 18 | 34629295 | Differential roles of interferons in innate responses to mucosal viral infections. | Trends Immunol | 2021 | https://conductscience.org/library/papers/34629295 | PubMed |
| 19 | 33085491 | Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands. | J Phys Chem Lett | 2020 | https://conductscience.org/library/papers/33085491 | PubMed |
| 20 | 34168168 | In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin. | Sci Rep | 2021 | https://conductscience.org/library/papers/34168168 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40716111 | A Unified Explanation for Drug Repurposing and Pharmacological Pleiotropy Based on Classical and Statistical Thermodynamics. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/40716111 | PubMed |
| 37325453 | COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 disease. | Heliyon | 2023 | https://conductscience.org/library/papers/37325453 | PubMed |
| 37234934 | Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2. | Microb Risk Anal | 2023 | https://conductscience.org/library/papers/37234934 | PubMed |
| 36974134 | SARS-CoV-2 strain wars continues: Chemical and thermodynamic characterization of live matter and biosynthesis of Omicron BN.1, CH.1.1 and XBC variants. | Microb Risk Anal | 2023 | https://conductscience.org/library/papers/36974134 | PubMed |
| 36804126 | XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2. | Microbiol Res | 2023 | https://conductscience.org/library/papers/36804126 | PubMed |
| 36777740 | Never ending story? Evolution of SARS-CoV-2 monitored through Gibbs energies of biosynthesis and antigen-receptor binding of Omicron BQ.1, BQ.1.1, XBB and XBB.1 variants. | Microb Risk Anal | 2023 | https://conductscience.org/library/papers/36777740 | PubMed |
| 36312211 | Why doesn't Ebola virus cause pandemics like SARS-CoV-2? | Microb Risk Anal | 2022 | https://conductscience.org/library/papers/36312211 | PubMed |
| 36168893 | Perspectives of (/memorandum for) systems thinking on COVID-19 pandemic and pathology. | J Eval Clin Pract | 2023 | https://conductscience.org/library/papers/36168893 | PubMed |
| 36034590 | Strain wars 5: Gibbs energies of binding of BA.1 through BA.4 variants of SARS-CoV-2. | Microb Risk Anal | 2022 | https://conductscience.org/library/papers/36034590 | PubMed |
| 35434234 | Strain wars 3: Differences in infectivity and pathogenicity between Delta and Omicron strains of SARS-CoV-2 can be explained by thermodynamic and kinetic parameters of binding and growth. | Microb Risk Anal | 2022 | https://conductscience.org/library/papers/35434234 | PubMed |
| 35106955 | Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106955 | PubMed |
| 35106934 | Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106934 | PubMed |
| 35029046 | "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35029046 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35106955
GET https://conductscience.org/api/papers/v1/35106955/references?page=2